Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 1

Interventions

Cisplatin 130 Radiotherapy 94 Carboplatin 85 Fluorouracil 79 Paclitaxel 78 Cyclophosphamide 77 Gemcitabine 72 Capecitabine 66 Docetaxel 65 Doxorubicin 60 Oxaliplatin 59 Etoposide 57 Leucovorin 50 Vincristine 47 Chemotherapy, Adjuvant 42 Cytarabine 38 Dexamethasone 35 Drug Therapy 33 Bevacizumab 31 Epirubicin 29 Neoadjuvant Therapy 28 Pemetrexed 27 Tamoxifen 25 Irinotecan 25 Prednisone 24 Rituximab 21 Methotrexate 21 Radiotherapy, Intensity-Modulated 19 apatinib 18 Vinorelbine 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Unknown × Human Papillomavirus DNA Tests × Clear all

NCT04794660 2024-03-13

CESTA

International Agency for Research on Cancer

Phase 3 Unknown

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡